Precigen Inc (NASDAQ: PGEN) kicked off on Friday, down -3.05% from the previous trading day, before settling in for the closing price of $1.64. Over the past 52 weeks, PGEN has traded in a range of $0.65-$2.17.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -19.53% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 42.98%. With a float of $162.39 million, this company’s outstanding shares have now reached $292.87 million.
In an organization with 143 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -29.11%, operating margin of -3440.31%, and the pretax margin is -3261.86%.
Precigen Inc (PGEN) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Precigen Inc is 44.77%, while institutional ownership is 25.87%. The most recent insider transaction that took place on Aug 09 ’24, was worth 50,000. In this transaction SVP, IP Affairs of this company bought 58,823 shares at a rate of $0.85, taking the stock ownership to the 743,097 shares. Before that another transaction happened on Aug 09 ’24, when Company’s Director bought 23,529,411 for $0.85, making the entire transaction worth $19,999,999. This insider now owns 64,547,214 shares in total.
Precigen Inc (PGEN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.98% per share during the next fiscal year.
Precigen Inc (NASDAQ: PGEN) Trading Performance Indicators
Take a look at Precigen Inc’s (PGEN) current performance indicators. Last quarter, stock had a quick ratio of 4.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 119.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.48, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach 0.03 in one year’s time.
Technical Analysis of Precigen Inc (PGEN)
Let’s dig in a bit further. During the last 5-days, its volume was 1.25 million. That was inferior than the volume of 1.93 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 13.88%. Additionally, its Average True Range was 0.14.
During the past 100 days, Precigen Inc’s (PGEN) raw stochastic average was set at 61.81%, which indicates a significant increase from 10.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.15% in the past 14 days, which was lower than the 92.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6490, while its 200-day Moving Average is $1.2455. However, in the short run, Precigen Inc’s stock first resistance to watch stands at $1.6300. Second resistance stands at $1.6700. The third major resistance level sits at $1.7000. If the price goes on to break the first support level at $1.5600, it is likely to go to the next support level at $1.5300. The third support level lies at $1.4900 if the price breaches the second support level.
Precigen Inc (NASDAQ: PGEN) Key Stats
The company with the Market Capitalisation of 467.53 million has total of 294,043K Shares Outstanding. Its annual sales at the moment are 3,930 K in contrast with the sum of -126,240 K annual income. Company’s last quarter sales were recorded 1,190 K and last quarter income was -19,730 K.
